- Wednesday, March 22, 2023
8:45 AM – 10:00 AM
(1) Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's Disease
8:45 AM – 10:00 AM
(R1) Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's DiseaseFaculty: – Magellan Rx Management
Faculty: – Magellan Rx Management
Managed Care Research in Action
Yuqian Liu, PharmD – Magellan Rx Management ### 583356###Faculty###Sr. Director, Specialty Clinical Solutions###Magellan Rx Management###Faculty: – Magellan Rx Management
### @@@ Simone Ndujiuba, PharmD, BCOP (she/her/hers) – Magellan Rx Management ### 1780600###Faculty###Director, Clinical Strategy and Innovation, Oncology###Magellan Rx Management###Faculty: – Magellan Rx Management
### she/her/hers10:30 AM – 11:45 AM
(2) IRON-ing Out the Details: Beta Thalassemia Landscape, Emerging Treatments, and Payer Considerations
10:30 AM – 11:45 AM
(D2) IRON-ing Out the Details: Beta Thalassemia Landscape, Emerging Treatments, and Payer ConsiderationsFaculty: – IPD Analytics, LLC
Faculty: – IPD Analytics
Drugs, Diseases, and the Managed Care Impact
Jennifer Billings, PharmD, BCGP (she/her/hers) – IPD Analytics, LLC ### 1836165###Faculty###Director, Clinical Pharmacy###IPD Analytics, LLC###Faculty: – IPD Analytics, LLC
### she/her/hers @@@ Julia Mahler, PhamD (she/her/hers) – IPD Analytics ### 1836166###Faculty###Clinical Pharmacist###IPD Analytics###Faculty: – IPD Analytics
### she/her/hers10:30 AM – 11:45 AM
(3) Federal Legislative and Regulatory Update
10:30 AM – 11:45 AM
(L2) Federal Legislative and Regulatory UpdateFaculty: – AMCP
Faculty: – AMCP
Legislative and Regulatory Trends
Jennifer L. Mathieu, MA (she/her/hers) – AMCP ### 1139240###Faculty###Vice President, Policy and Government Relations###AMCP###Faculty: – AMCP
### she/her/hers @@@ Geni Tunstall, JD (she/her/hers) – AMCP ### 1752576###Faculty###Director, Regulatory Affairs###AMCP###Faculty: – AMCP
### she/her/hers10:30 AM – 11:45 AM
(4) Measuring Medical Cost Offsets from Improvements in Medication Adherence Using Real-World Data
10:30 AM – 11:45 AM
(M2) Measuring Medical Cost Offsets from Improvements in Medication Adherence Using Real-World Data Faculty: – RxEconomics LLC
Faculty: – Prime Therapeutics, LLC
Focus on Managed Care Pharmacy
M. Christopher Roebuck, PhD MBA – RxEconomics LLC ### 1855443###Faculty###CEO###RxEconomics LLC###Faculty: – RxEconomics LLC
### @@@ Ben Urick, PharmD, PhD – Prime Therapeutics, LLC ### 1779868###Faculty###Health Outcomes Research Principal###Prime Therapeutics, LLC###Faculty: – Prime Therapeutics, LLC
### 10:30 AM – 11:45 AM
(5) Challenges and Opportunities in Collecting Data to Address Health Disparities
10:30 AM – 11:45 AM
(R2) Challenges and Opportunities in Collecting Data to Address Health DisparitiesFaculty: – Excellus BlueCross BlueShield
Faculty: – Healthfirst
Faculty: – UMass Chan Medical School - Commonwealth Medicine
Managed Care Research in Action
Christopher Diehl, PharmD, MBA, BCACP (he/him/his) – Excellus BlueCross BlueShield ### 574886###Faculty###Manager, Clinical Pharmacy Programs###Excellus BlueCross BlueShield###Faculty: – Excellus BlueCross BlueShield
### he/him/his @@@ Hannah Lee-Brown, PharmD, CPHQ – Healthfirst ### 1591726###Faculty###Director, Pharmacy Benefits###Healthfirst###Faculty: – Healthfirst
### @@@ Thomas C. Pomfret, PharmD, MPH, BCPS (he/him/his) – UMass Chan Medical School - Commonwealth Medicine ### 966901###Faculty###Clinical Consultant Pharmacist Team Lead, Residency Program Director###UMass Chan Medical School - Commonwealth Medicine###Faculty: – UMass Chan Medical School - Commonwealth Medicine
### he/him/his3:15 PM – 4:30 PM
(6) Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management
3:15 PM – 4:30 PM
(D3) Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease ManagementFaculty:
Faculty: – Kaiser Foundation Health Plan of the Northwest
Drugs, Diseases, and the Managed Care Impact
Kayla Braestrup ### 1876009###Faculty#########Faculty:
### @@@ Lynsey Smith, PharmD, BCACP – Kaiser Foundation Health Plan of the Northwest ### 583138###Faculty###Clinical Pharmacy Specialist in Rheumatology and Dermatology###Kaiser Foundation Health Plan of the Northwest###Faculty: – Kaiser Foundation Health Plan of the Northwest
### 3:15 PM – 4:30 PM
(7) AMCP Market Insights Best Practice: Strategies for Antibody-Drug Conjugates to Deliver Improved Patient Outcomes
3:15 PM – 4:30 PM
(M3) AMCP Market Insights Best Practice: Strategies for Antibody-Drug Conjugates to Deliver Improved Patient OutcomesFocus on Managed Care Pharmacy
3:15 PM – 4:30 PM
(8) Podium Session – Award-winning Research Supporting the Managed Care Pharmacy Research Agenda
3:15 PM – 4:30 PM
(R3) Podium Session – Award-winning Research Supporting the Managed Care Pharmacy Research AgendaFaculty: – Janssen Scientific Affairs, LLC
Faculty: – CVS Health Clinical Trial Services
Faculty: – Presbyterian College School of Pharmacy
Faculty: – Prime Therapeutics, LLC
Moderator: – University of Florida, Journal of Managed Care and Specialty Pharmacy
Managed Care Research in Action
Carmela Benson, MS, MSHP – Janssen Scientific Affairs, LLC ### 1295375###Faculty###Group Director, Real-World Value and Evidence###Janssen Scientific Affairs, LLC###Faculty: – Janssen Scientific Affairs, LLC
### @@@ Jennifer Pigoga, PhD, MPH, MSc (she/her/hers) – CVS Health Clinical Trial Services ### 1857156###Faculty###Lead Data Scientist###CVS Health Clinical Trial Services###Faculty: – CVS Health Clinical Trial Services
### she/her/hers @@@ Kayce Shealy, PharmD, BCPS, CDCES (she/her/hers) – Presbyterian College School of Pharmacy ### 1865703###Faculty###Professor, Pharmacy Practice###Presbyterian College School of Pharmacy###Faculty: – Presbyterian College School of Pharmacy
### she/her/hers @@@ Ben Urick, PharmD, PhD – Prime Therapeutics, LLC ### 1779868###Faculty###Health Outcomes Research Principal###Prime Therapeutics, LLC###Faculty: – Prime Therapeutics, LLC
### @@@ Laura Happe, PharmD, MPH – University of Florida, Journal of Managed Care and Specialty Pharmacy ### 800154###Moderator###Associate Professor, Editor-in-Chief###University of Florida, Journal of Managed Care and Specialty Pharmacy###Moderator: – University of Florida, Journal of Managed Care and Specialty Pharmacy
### 3:15 PM – 4:30 PM
(9) The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications
3:15 PM – 4:30 PM
(W3) The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment MedicationsMaking the Way for Innovation
Rick Lassow ### 1876012###Faculty#########Faculty:
###
